Terumo is engaged in the manufacture and sale of medical products and equipment. Co.'s principal businesses are cardiac and vascular, general hospital, and blood management. Co.'s principal products are I.V. catheter, nelaton catheter, surgical tape, wound care dressing, syringe hypodermic needle, safety syringe and IV administration set; angiographic catheter, PTCA dilatation catheter, coronary stent, microcatheter and artificial vascular grafts; automated blood collection system, automated blood component processing device, blood bag system with leukocyte reduction filter, sterile tubing welder, pathogen reduction technology system, therapeutic apheresis system, and cell expansion system.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.